Breakthrough in CRISPR Gene Editing Accuracy
Our team has developed a new CRISPR variant with 99.9% accuracy, opening doors for therapeutic applications.
Pioneering breakthrough discoveries in genomics, proteomics, and drug discovery. From bench to bedside, our 100+ researchers transform cutting-edge science into life-changing therapies.
From fundamental discoveries to applied research, we tackle the most challenging questions in modern biology.
Single-cell sequencing, spatial transcriptomics, and CRISPR-based gene editing. Decoding genomic variation to understand disease mechanisms and develop precision therapies.
Cryo-EM structural biology, quantitative mass spectrometry, and interactome mapping. Elucidating protein function to accelerate drug target identification.
AI-powered virtual screening, fragment-based lead optimization, and ADMET prediction. Reducing the 10-year drug development cycle through computational innovation.
CRISPR crop engineering, microbiome optimization, and sustainable biopesticide development. Addressing global food security through molecular biology.
Enzyme engineering, metabolic pathway optimization, and bioprocess scale-up. Converting renewable feedstocks into high-value chemicals and materials.
Stay informed about our latest breakthroughs and initiatives.
Our team has developed a new CRISPR variant with 99.9% accuracy, opening doors for therapeutic applications.
KBR joins forces with MIT to accelerate AI-driven drug discovery for rare diseases.
State-of-the-art facility expands our capabilities in structural biology and protein characterization.
Whether you're a researcher seeking collaboration, a company looking for innovative solutions, or a talented individual ready to make an impact -- we'd love to hear from you.
Partner with us on groundbreaking research projects
Leverage our expertise for your business challenges
Join our team of world-class researchers